Rational Combinations 360 2018 is a conference dedicated to clinical advancements, business aspects and scientific data in Immuno-Oncology combination strategies to fight a wider range of cancers.
Rational Combinations 360 2018 covers topics such as:
- Translational Science
- Discovery / Preclinical Science
- Business Aspects
- Clinical Operations & Development
- Emerging Technologies
- Financial & Commercial Implications
- Trends in the Field
- Biomarkers & Diagnostics
Rational Combinations 360 2018 brings together:
- Academia & Research Organizations focusing on
- Immunotherapy
- Immuno-Oncology
- Immunology
- Oncology
- Cancer Vaccines
- Immunobiology
- Clinical Research and Development
- Adoptive T-Cell Therapy
- Large Pharma/Biopharma/Biotech responsible for
- Business Development: Corporate Venture, Licensing, Strategic Partnerships, Negotiations, Early-stage Collaboration, Commercial Innovation, External R&D
- R&D: Clinical Research/Development, Clinical Operations, Clinical Oncology, Cancer Immunotherapy, Immunology, Translational Research/Development/Medicine, Medical Affairs, R&D Innovation & Strategy, Biomarkers
- Solution Providers
- Consultants/Advisors
- CROs
- Technology/Medical Device Platforms
- Law Firms
- Investment Community
- Venture Capitals
- Investment Firms
- Foundation Capital
- Banks/Financial Institutions
